Where does Diego Rey work?

Diego Rey is Founder/CSO of Endpoint Health.

What check size does Diego Rey write?

Diego Rey typically writes checks of $50K – $1M.

What companies did Diego Rey found?

Diego Rey founded Endpoint Health.

Where did Diego Rey go to school?

Diego Rey studied at Cornell University (MS & PhD, Biomedical Engineering); UC Santa Barbara (BS, with Honors); Palo Alto High School.

Diego Rey

Founder

Founder/CSO at Endpoint Health

San Francisco, California

Writes $50K – $1M checks · typically $50K

FoundedEndpoint Health · YC

About

Diego Rey is the Chief Executive Officer of Gemini Therapeutics, a company developing aldoxorubicin, a tumor-targeted chemotherapy that has completed 16 clinical trials and received five orphan drug designations. He previously co-founded GeneWEAVE Biosciences, where he served as Chief Technology Officer and is named as author on 27 issued patents, and co-founded Endpoint Health, serving as Chief Scientific Officer and board member. Rey holds a BS in Electrical Engineering from UC Santa Barbara and a PhD from Cornell University, was the first Visiting Partner focused on life sciences and healthcare at Y Combinator, and serves on the Cornell University College of Engineering Council.

Founder/CSO at Endpoint Health YC W19

Intro paths

Diego went through Y Combinator (Winter 2019) — any YC alum in your network can reach them through the YC community.

→

In turn, Diego can intro founders to Endpoint Health's investors below.

Endpoint Health's investors · 5

Alix VenturesSan Francisco · $100K – $500K checks AME Cloud VenturesPalo Alto · $1M – $10M checks Boom Capital VenturesSan Francisco · $50K – $300K checks Knockout CapitalSan Francisco Y CombinatorSan Francisco · $500K checks · since 2019

Co-founders at Endpoint Health

Jeff OsbornFounder

Jason SpringsFounder

Leonardo TeixeiraFounder

Leonardo Maestri TeixeiraFounder

Experience

Gemini TherapeuticsChief Executive Officercurrent2025 — presentSan Francisco, California, United States
Endpoint VenturesAngel investingcurrent2018 — presentSan Francisco Bay Area
ENDPOINT HEALTHCo-Founder & Chief Scientific Officer2018 — 2024Palo Alto, CA
Y CombinatorExpert/Part time Partner2018 — 2021San Francisco Bay Area
Y CombinatorVisiting Partner2017 — 2018San Francisco Bay Area
Roche Molecular SystemsHead of Research, GeneWEAVE Division of Roche Molecular Systems2015 — 2017Los Gatos, CA
GeneWEAVECo-Founder & Chief Technology Officer2010 — 2015Los Gatos, CA
Batt Research GroupGraduate Research Assistant2004 — 2010Tompkins County, New York, United States

Skills & more

Biotechnology64Lifesciences16Venture Capital8Early-stage Startups3Nanotechnology44Biomedical Engineering15Start-ups99Medical Devices33R&D25Molecular Biology19Commercialization24Entrepreneurship68

+12 more

Technology TransferProduct DevelopmentPatentsBiochemistryCell CultureMicroscopyNanofabricationDrug DiscoveryCharacterizationDue DiligenceIntellectual PropertyLife Sciences

Languages Spanish

From Diego's professional profile.

Frequently asked questions

Who is Diego Rey?: Diego Rey is the Chief Executive Officer of Gemini Therapeutics, a company developing aldoxorubicin, a tumor-targeted chemotherapy that has completed 16 clinical trials and received five orphan drug designations. He previously co-founded GeneWEAVE Biosciences, where he served as Chief Technology Officer and is named as author on 27 issued patents, and co-founded Endpoint Health, serving as Chief Scientific Officer and board member. Rey holds a BS in Electrical Engineering from UC Santa Barbara and a PhD from Cornell University, was the first Visiting Partner focused on life sciences and healthcare at Y Combinator, and serves on the Cornell University College of Engineering Council.
Where does Diego Rey work?: Diego Rey is Founder/CSO of Endpoint Health.
What check size does Diego Rey write?: Diego Rey typically writes checks of $50K – $1M.
What companies did Diego Rey found?: Diego Rey founded Endpoint Health.
Where did Diego Rey go to school?: Diego Rey studied at Cornell University (MS & PhD, Biomedical Engineering); UC Santa Barbara (BS, with Honors); Palo Alto High School.